Active Ingredient: LIFITEGRAST
Proprietary Name: XIIDRA
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 5%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208073
Product Number: 001
Approval Date: Jul 11, 2016
Applicant Holder Full Name: BAUSCH AND LOMB INC
Marketing Status:
Prescription
Patent and Exclusivity Information